endocrinology board review september 24, 2010. growth

88
ENDOCRINOLOGY BOARD REVIEW September 24, 2010

Upload: jane-ackerly

Post on 15-Dec-2015

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

ENDOCRINOLOGY BOARD REVIEW

September 24, 2010

Page 2: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Growth

Page 3: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Growth

After 18mos of age, growth curve should be followed closely Between 4y/o and adolescence, growth

below 4-5cm/yr should be assessed Percentiles should not be crossed

Pubertal growth spurt Girls early puberty Boys midpuberty

Page 4: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Growth Rate per Year

Age Inches Centimeters

Birth to 1 year 7 to 10 18 to 25

1 to 2 years 4 to 5 10 to 13

2 years to puberty 2 to 2.5 5 to 6

Pubertal growth spurt-girls

2.5 to 4.5 6 to 11

Pubertal growth spurt-boys

3 to 5 7 to 13

Page 5: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 1

Choose the correct statement comparing “familial or genetically determined short stature” and “constitutional delay of growth,” in regards to bone age.

A. Familial = delayed/ constitutional = advanced

B. Familial = equivalent/ constitutional = delayed

C. Familial = delayed/ constitutional = equivalent

D. Both are delayed

Page 6: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Constitutional delay of growth Variant of normal growth and pubertal

development Period of decreased linear growth within

first 3yrs of life Downward crossing of percentiles

Linear growth resumes at normal rate Along lower growth percentiles

Family history of “Late Bloomers”

Page 7: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Constitutional Growth Delay: Note deceleration followed by normal growth rate

Page 8: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 2

The physical findings depicted below corresponds to which tanner stage?

A. IB. IIC. IIID. IVE. V

Page 9: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Tanner Staging

Boys: Staged by genital development and pubic hair – starts at 9-14 Testis volume >= 4mL is pubertal

Mark of pubertal onset Girls: Staged by breast development and

pubic hair – starts at 10 ½ Stage II = breast buds

Mark of pubertal onset Stage IV = Areola elevated above breast

(secondary mound)

Page 10: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Hypothalamus and Pituitary

Page 11: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Hypothalamus

Neuroectodermal tissue

Inferior third ventricle

Pituitary stalk

Page 12: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Pituitary

Anterior Upgrowth of

ectodermal cells from Rathke’s pouch

Posterior Downgrowth of

neural tissue cells from the hypothalamus

Page 13: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 3

You are evaluating a patient in clinic and notice the abnormality pictured. Which of the following is most likely to be affected?

A. Growth hormone levels

B. Aldosterone levelsC. Catecholamine

levelsD. Insulin levels

Page 14: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Anterior Pituitary

Growth Hormone

Secretion GH-releasing factor

Inhibition Somatostatin

IGF-1, IGF-BP3

Page 15: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Anterior Pituitary

Growth Hormone Deficiency

Normal birth weight Normal growth pattern x

1 year “Kewpie” doll

appearance, “cherubic” Short, excess subq fat,

retarded body proportion changes and high-pitched voices

Diagnosed with stimulation test

Page 16: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Anterior Pituitary

ACTH

Secretion CRF from

hypothalamus

Inhibition Cortisol from

adrenals Prolonged steroid

use

Page 17: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Anterior Pituitary

Gonadotropins Secretion

GnRH Hypothalamus sends

pulses Increases during puberty

Inhibition Inhibin

FSH Aromatase (androgen to

estrogen) Spermatogenesis

LH Testosterone Androstenedione (estradiol)

Page 18: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Anterior Pituitary

TSH

Secretion TRH

Inhibition Thyroid Hormone

Actions Increases iodide

uptake, thyroglobulin synthesis and thyroid hormone

Page 19: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Anterior Pituitary

Prolactin Acts directly on target organ Initiation and maintenance of lactation Inhibited by dopamine from hypothalamus Hyperprolactinemia

Galactorrhea Pituitary adenomas Medication

Neuroleptics, antipsychotics, estrogens and anti-hypertensives

Page 20: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 4

You are on call in the PICU and following a very sick patient admitted with meningococcal meningitis. He has not had any urine output in the last 8 hours despite fluid administration. You order a BMP and his Na is 125. What is the most likely cause of the hyponatremia in this patient?

A. Diabetes insipidusB. Psychogenic polydipsiaC. Inappropriate fluid administrationD. SIADH

Page 21: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Posterior Pituitary

Hormones synthesized in hypothalamus and stored in posterior pituitary

Vasopressin AVP or ADH Released in response to increased osmotic

pressure in the blood Water balance

Increased reabsorption of water in collecting ducts of kidneys

Arteriolar vasoconstriction – HTN Increased thirst

Page 22: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Posterior Pituitary

Vasopressin Overproduction

Head trauma, brain tumors, encephalitis, pneumonia

SIADH HA, apathy, nausea, vomiting, impaired consciousness Decreased plasma osmolarity

Underproduction Central Diabetes Insipidus (DI)

Pituitary tumors, head trauma, infiltrative diseases, autoimmune or surgical

Increased plasma osmolarity

Page 23: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Posterior Pituitary

Vasopressin Resistant

Nephrogenic DI Tubules in kidney cannot respond Genetic or acquired (lithium)

Oxytocin Released in response to nerve stimulation Contraction of the smooth muscle of the

uterus and myoepithelial cells lining the ducts of mammary glands

Page 24: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Page 25: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Location Neck Base of tongue Mediastinum

Hormones Thyroxine (T4) Tri-iodothyronine (T3) Need iodine for synthesis Transported by TBG,

albumin and transthyretin Free hormone is active

Page 26: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Goiter Hyper or hypo

Nodules 70-80% benign or cystic 1-1.5% of all childhood

cancers Neck irradiation, family

history of medullary carcinoma, rapid growth, fixation to adjacent structures, enlarged lymph nodes

Page 27: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 5

A mother brings in her teenage daughter for hyperactivity and emotional lability. ROS is positive for diarrhea, weight loss and heat intolerance. On physical exam you notice tachycardia and a slight prominence of the eyes. A laboratory evaluation would most likely reveal:A. TSH, freeT4, + TSH receptor antibodiesB. TSH, free T4, + antithyroperoxidase antibodiesC. TSH, free T4, + TSH receptor antibodiesD. TSH, free T4, + antithyroperoxidase antibodies

Page 28: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Hyperthyroid Soft and fleshy gland Tachycardia Weight loss Increased frequency of

bowel movements Heat intolerance Nervousness Widened pulse

pressure Tremor Fatigue

Warm, moist skin Fine, friable hair Separation of distal

margin of nail bed Restlessness Inability to sit still Emotional lability Short attention

span Excessive sweating

Page 29: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Hyperthyroidism Graves Disease

Stimulating antibody to TSH receptor

Exopthalmos Proptosis and lid lag

Large gland Warm on palpation

Bruit Labs

Increased T3 and T4 Decreased TSH

Page 30: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Congenital Hypothyroidism 1 in 4000 Cretinism

Broad nasal bridge Coarse facial features Mental retardation Short stature Puffy hands Protuberant tongue Delayed skeletal maturation

Treatment within 3-4 weeks

Newborn Screening

Page 31: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Hypothyroid Hypothalamic abnormalities Pituitary abnormalities Iodine deficiency Chronic lymphocytic thyroiditis Hashimoto thyroiditis

Anti-thyroid antibodies Thyroglobulin Thyroperoxidase

Positive FH Increased TSH, decreased T4

Page 32: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Thyroid

Hypothyroid symptoms Firm or bosselated gland Congenital vs Acquired Dry skin Constipation Hair loss Fatigue Cold intolerance Apathy Depressed or delayed relaxation

Page 33: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Acquired hypothyroidism: Note the sharp deceleration in growth before the onset of symptoms. Following initiation of therapy significant catch-up growth is seen.

Page 34: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Calcium and Phos Metabolism

Page 35: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

PTH

Bone: Increases release of Ca and Phos

Intestine: Increased re-absorption of Ca and Phos

Kidney: Increases excretion of Phos Decreases excretion of Ca Stimulates Synthesis of Vit D3

Page 36: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Effects of PTH

Bone Intestine

Kidney Net Effect

Ca

Phos

Page 37: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Vitamin D

Bone Increases release of Ca Increases release Ph

Intestine Increases absorption of Ca Increases absorption of Ph

Kidney Improves reabsorption of Ca Increases reabsorption of Ph

Page 38: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Vitamin D

Bone Intestine

Kidney Net Effect

Ca

Phos

Page 39: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Calcitonin

Bone Inhibits reabsorption of Ca Inhibits reabsorption of Ph

Intestine (no specific effects)

Kidney Decreases reabsorption of Ca Decreases reabsorption of Ph

Page 40: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Net Effect of 3 Hormones

Ca Phos

Vit D

PTH

Calcitonin

Page 41: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Hyperparathyroidism

Results in hypercalcemia

Manifestation of multiple endocrine neoplasia I (MEN 1) Autosomal dominant Islet cell tumors Zollinger-Ellison syndrome Pituitary tumors

Page 42: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Symptoms:ParesthesiasIrritabilityMuscle CrampsTetanySeizures

Hypocalcemia

Page 43: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 6

A two day old infant experiences a prolonged seizure with respiratory arrest requiring intubation. BMP reveals hypocalcemia, and CXR demonstrates absent thymic shadow. Genetic testing is likely to reveal:

A. Trisomy 21B. Trisomy 18C. Deletion of 22q11.2D. Deletion of 15q13.3E. DF508 Mutation

Page 44: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Hypoparathyroidism

Idiopathic (Autoimmune) DiGeorge Syndrome

Dysmorphic features Cardiac defects Immune deficiency Thymic aplasia Low PTH Deletion of 22q11.2 May present with seizures secondary to

hypocalcemia

Ca low

P high

PTH low

Page 45: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Pseudohypoparathyroidism

PTH is elevated Unresponsiveness to PTH

(Bone/Kidney/Both) Albright hereditary osteodystrophy

Suspect in short child with hypocalcemia

Ca lowP highPTH high

Page 46: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Albright hereditary osteodystrophy

Page 47: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Vitamin D-Deficient Rickets

Vitamin D deficiency may result from Inadequate sunlight exposure Malabsorption Drugs that affect Vit D

Phenytoin, phenobarb Signs/Symptoms

Poor linear growth Delayed walking Muscle weakness Bone pain Hypotonia Anorexia

Ca NL/lowP lowPTH highAlkP high

Page 48: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Vitamin D-Deficient Rickets

Page 49: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Others

Vitamin D-Resistant Rickets Resistance to Vit D, even when high

amounts used Findings in first months of life

Pseudovitamin D-Deficiency Rickets AKA 1 -a hydroxylase deficiency or Vit-D

dependent rickets type I Findings appear in early infancy Autosomal recessive

Page 50: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenals

Page 51: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

Cortex Glucocorticoids Mineralocorticoids Androgens

Medulla Epinephrine Norepinephrine

Page 52: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Glands

Cushing Excessive glucocorticoids

Endogenous or exogenous steroid exposure

Causes Adrenal tumors Pituitary adenomas (Cushing disease) Ectopic ACTH production

Page 53: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

Features of Cushings Rounded facies Plethora Central obesity Impaired linear growth Fatigue Hypertension Buffalo hump Muscle weakness and muscle wasting Skin is thin and easily bruised Osteopenia/osteoporosis

Page 54: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

Cushings Labs Elevated 24-hour

urine free cortisol excretion

Elevated salivary cortisol

Delineating the cause High- and low-

dose dexamethasone suppression tests

Page 55: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

Addison’s Disease Insufficiency

Glucocorticoid Mineralocorticoid

Causes Autoimmune destruction Tuberculosis Autoimmune polyendocrine syndromes Adrenoleukodystrophy, Wolman disease, hereditary

unresponsiveness to ACTH, Allgrove syndrome, and congenital adrenal hypoplasia

Massive adrenal hemorrhage can occur with meningitis or traumatic births

Page 56: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

Addison’s Weight loss Wasting of

subcutaneous tissue

Hyperpigmentation Weak Confused Decreased

circulating plasma volume

Page 57: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

Addison Labs

Hyponatremia Hyperkalemia

Less pronounced disease in ACTH deficiency

If untreated Weaken Vascular collapse

Page 58: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 7

A 3-week-old female infant is brought to the ER for vomiting, decreased oral intake and lethargy of 3 days’ duration. Because the infant had not regained her birthweight at the 2-week visit, the mother was instructed to wake her every 2 hours to breastfeed. On PE, the infant’s temp is 98.6F, HR 190, BP 60/30. She appears thin and lethargic and has a poor suck. Her anterior fontanelle and eyes appear sunken, and her CR is 3 secs. You note an enlarged clitoris and partial labial fusion. Assessment of serum electrolytes in this infant is MOST likely to reveal

A. HyperchloremiaB. HyperglycemiaC. HypernatremiaD. HypokalemiaE. Hyponatremia

Page 59: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

CAH Autosomal recessive Symptoms reflect specific defect

21-hydroxylase deficiency Most common Decreased glucocorticoid

Hypoglycemia Decreased mineralocorticoid (severe forms)

Salt-wasting Hyperkalemia/hyponatremia

Elevated 17-hydroxyprogesterone Excess androgens

Masculinization Shock and death if untreated

Page 60: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth
Page 61: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland

Other forms of CAH Less severe 21-hydroxylase deficiency

May present later Premature pubarche, rapid growth, skeletal

maturation

11β-hydroxylase

17α-hydroxylase Delayed puberty Undervirilization of males

Page 62: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Adrenal Gland - Medulla

Pheochromocytoma Rare Catecholamine-secreting tumor

Norepinephrine, Epinephrine, Dopamine (rarely) Symptoms

HA, diaphoresis, palpitaions, tremor, nausea, weakness, anxiety, weight loss

Hypertension (episodic), AMS, arrhythmia Syndromes

MEN 2A, 2B, NF, VHL Diagnosis

Plasma metanephrines, 24-hour urine catecholamines and metanephrine

Page 63: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Sexual Differentiation

Page 64: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Sexual Differentiation

SRY gene Short arm of Y chromosome Promotes differentiation of Sertoli cells Mutations lead to male to female sex

reversal Ambiguous genitalia

“the baby” Endocrine, urology, psychologist or social

worker Palpate for gonads

Page 65: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Sexual Differentiation

Ambiguous Genitalia CAH

No palpable gonads 17-hydroxyprogesterone

Leydig cell hypoplasia, inborn errors of testosterone synthesis, androgen insensitivity Palpable gonads LH, FSH, testosterone,

dihydrotestosterone Complete androgen

insensitivity Externally female Uterus absent Labial or inguinal gonads

Page 66: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Sexual Differentiation

Persistent mullerian duct syndrome Persistance of structures

in normal 46,XY male Cryptorchidism or

testicular ectopia Defect in anti-mullerian

hormone Agenesis of the phallus

Developmental

Page 67: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 8

You are examining a 2-week-old male infant for the first time and note an undescended right testicle. His mother asks when is the optimal time to correct this problem.

The MOST appropriate time at which to recommend surgical repair for this infant if spontaneous descent has not occurred is

A. 4 monthsB. 12 monthsC. 24 monthsD. 36 monthsE. 48 months

Page 68: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Cryptorchidism

Migration Kidneys to scrotum 3% of male infants Treatment

6-12 months Orchiopexy

Increased risk for malignancy Surgical intervention

does not alter risk

Page 69: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Precocious Puberty

Page 70: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Precocious Puberty

Girls <8

Boys <9

Central Gonadotropin-dependent

Activation of HPG axis FSH, LH

Hypothalamic hamartomas Gelastic seizures

Intracranial neoplasms

Page 71: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Precocious Puberty

Gonadotropin-independent Increased gonadal steroids No HPG axis involvement McCune-Albright syndrome

Café-au-lait Polyostotic fibrous dysplasia Precocious puberty

Gonadal or adrenal neoplasms Rare

Familial male-limited precocious puberty

Page 72: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 9

During the hospital discharge examination of a term female neonate, you palpate a 1-cm mass beneath her right nipple. There is no erythema at the site and no discharge from either nipple. The mass is nontender and freely mobile. The genitalia appear mildly swollen but are otherwise normal.

Of the following, the MOST appropriate treatment is

A. Excisional biopsyB. Fine-needle aspiration of the massC. IM gonadotropin-releasing hormoneD. Oral cephalexinE. Reassurance of the parents

Page 73: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Premature Thelarche

Breast tissue development Uni or bilateral May regress or persist

Diagnosis of exclusion No other signs of pubertal

development Exogenous estrogen

1-2y Self-limited Normal in neonates

Page 74: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Premature Pubarche

Pubic hair <8y in girls; <9.5y boys

Axillary hair, body odor, acne

Due to Premature adrenal

pubertal maturation PCOS

Late onset CAH Tumor - rare

Page 75: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Delayed Puberty

Page 76: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Delayed Puberty

Constitutional Delay Normal variant

Central Kallmann Syndrome

Hypothalamic hypogonadism Acquired

Trauma, neoplasm, infiltrative disorders, hyperprolactinemia, chronic illness - anorexia, CF, sickle cell

Gonadal Turner, Klinefelter Trauma, chemotherapy, radiation

Page 77: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Delayed Puberty

Other Androgen insensitivity

Inguinal or labial mass Primary amenorrhea

17-hydroxylase deficiency Cannot produce sex steroids

Page 78: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Turner Syndrome

XO Short stature Gonadal failure

Streak ovaries Other

Cubitus valgus, shieldlike chest, webbed neck

Cardiac Renal

Mosaic

Page 79: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Klinefelter Syndrome

47, XXY

Small, firm testes

Gynecomastia

Neurobehavioral difficulties

Page 80: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

You will get more diabetes than you ever dream of on Purple team!

Diabetes

Page 81: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Hypoglycemia

Page 82: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth
Page 83: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Hypoglycemia

Signs and symptoms ANS, Epinephrine, CNS

glucopenia Fasting vs. Stress vs.

Iatrogenic

Hyperinsulinism Most common cause in

neonates Mutations of enzymes,

iatrogenic, adenoma Beckwith-Wiedemann

Macrosomia, macroglossia, omphalocele, hemihypertrophy and embryonal tumor

Page 84: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Hypoglycemia

Ketotic hypoglycemia Common cause of childhood hypoglycemia 18 months to 5 years Resolves by 8 to 9 years

Other Hypopituitarism, GSD, disorders of

gluconeogenesis

Page 85: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Obesity

Page 86: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Question 10

You care for a 17-year-old boy who is overweight. He has gained 44 lb (20 kg) in the last year, especially in his abdominal area. On examination today, his blood pressure is 158/90 mm Hg using a large, appropriately sized cuff. His mother has a similar body habitus and is being treated for type 2 DM. Of the following, the MOST likely abnormalities to expect in this patient if his presentation continues into adulthood is

A. High triglycerides and low HDLB. Hypoglycemia from insulin sensitivityC. Low concentrations of C-reactive protein in the bloodD. Low fibrinogen concentration with bleeding diathesesE. Low triglycerides and low LDL

Page 87: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth
Page 88: ENDOCRINOLOGY BOARD REVIEW September 24, 2010. Growth

Obesity

Look for causes of secondary obesity Endocrine Genetic CNS

Metabolic Syndrome Obesity Insulin resistance Dyslipidemia HTN Increased risk of developing Type 2 DM and

CV disease Look for PCOS

Hyperandrogenism, irregular menses, chronic anovulation